Apyx Medical (APYX) Revenue (2011 - 2026)

Apyx Medical (APYX) has 16 years of Revenue data on file, last reported at $12.5 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 32.45% year-over-year to $12.5 million; the trailing twelve-month figure through Mar 2026 stood at $55.9 million (up 18.22% YoY), and the FY2025 full-year result was $52.8 million, up 9.86% from the prior year.
• Revenue for Q1 2026 stood at $12.5 million, down from $19.2 million in the prior quarter.
• Across five years, Revenue topped out at $19.2 million in Q4 2025 and bottomed at $9.1 million in Q3 2022.
• The 5-year median for Revenue is $12.1 million (2024), against an average of $12.4 million.
• Peak annual rise in Revenue reached 44.63% in 2022, while the deepest fall reached 25.04% in 2022.
• A 5-year view of Revenue shows it stood at $12.6 million in 2022, then rose by 16.26% to $14.7 million in 2023, then slipped by 3.0% to $14.2 million in 2024, then jumped by 34.75% to $19.2 million in 2025, then tumbled by 34.83% to $12.5 million in 2026.
• The last three Revenue figures came in at $12.5 million (Q1 2026), $19.2 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.

Peer Comparison